Genome editing technologies have revolutionized the ability to rewire metabolic pathways and glycan biosynthetic machinery. Despite their power, these tools occasionally bind and cleave DNA sequences that are homologous but not identical to the intended target. These off-target effects lead to deleterious mutations, chromosomal translocations, or the disruption of essential regulatory networks within the chassis. In the context of glycobiology, undetected off-target effects could inadvertently silence a critical glycosyltransferase or divert the flux of sugar nucleotide precursors, resulting in suboptimal product quality or decreased strain stability. At CD BioGlyco, our service combines state-of-the-art bioinformatics, high-throughput sequencing, and advanced molecular biology to ensure that your engineered strains are as precise as your designs. By providing a rigorous assessment of the genomic landscape, we empower researchers to move from the laboratory to production with absolute confidence in their chassis' genetic integrity.
Key Technologies
Unbiased Genome-wide Discovery
Our unbiased genome testing detects double-strand breaks (DSBs) across the entire genome. These techniques capture the actual cleavage profile of a nuclease within the specific cellular environment of your chassis, revealing off-target effects (OTEs) that in silico algorithms might overlook due to complex chromatin structures or epigenetic variations.
Next-Generation Sequencing (NGS)
Once potential off-target sites are nominated through discovery or bioinformatic prediction, we employ ultra-deep NGS of polymerase chain reaction (PCR) amplicons to quantify mutation frequencies. By achieving sequencing depths exceeding 10,000x, we detect rare off-target events occurring in as few as 0.1% of the cell population.
High-Fidelity Nuclease Engineering
We utilize advanced high-fidelity (HiFi) variants that have been engineered for superior specificity. These enzymes significantly reduce off-target binding without sacrificing on-target efficiency. Furthermore, we optimize the delivery format, such as ribonucleoprotein (RNP) complexes, which limits the duration of nuclease exposure within the cell, further minimizing the window of opportunity for unintended genomic interactions.
Precision-Driven Chassis Engineering: Advanced Off-targeted Genome Editing Service
As a specialized component of our chassis strain development service, this offering is meticulously integrated into the broader chassis development hierarchy. We provide an end-to-end solution for monitoring and optimizing genome editing outcomes in a wide variety of hosts, including Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, and various mammalian cell lines used in glycoprotein production. Our service scope encompasses:
Targeted Assessment: Evaluating the specificity of existing gene editing systems in your proprietary strains.
Risk Mitigation: Re-engineering guide RNA (gRNA) sequences or selecting alternative nucleases to eliminate identified OTEs.
Strain Certification: Providing a "genomic health report" for your final production chassis is essential for regulatory filings and intellectual property protection.
Method Development: Customizing off-target detection protocols for non-traditional or extremophilic microbial chassis that lack standard genomic references.
Whether you are in the early stages of metabolic pathway design or the final stages of strain optimization, CD BioGlyco's experts are ready to assist.
Workflow
In Silico Target Site Analysis
We use proprietary algorithms to rank potential gRNA sequences based on their on-target efficiency and predicted off-target risk. This step filters out designs with high homology to critical metabolic or regulatory genes.
Chassis Transformation
Following the design phase, the optimized editing components are introduced into the chassis. Depending on the project requirements, we utilize plasmid-based delivery, mRNA, or RNP complexes.
Off-target Site Nomination
Using unbiased methods like digenome-seq, we identify the actual cleavage sites of the nuclease across the entire genome. This experimental nomination phase is crucial because it accounts for the unique genomic context of the chassis strain.
Amplicon Library Construction
Potential off-target sites identified, along with top-ranked in silico predictions, are selected for high-sensitivity validation. We design specialized primer panels to amplify these specific loci, creating a multiplexed library ready for deep sequencing.
Sequencing and Bioinformatics Analysis
The libraries are sequenced using high-capacity NGS platforms. Our bioinformatics pipeline then filters out sequencing artifacts, identifies genuine mutations, and quantifies their frequency relative to the on-target site.
Final Reporting and Consultation
The results are compiled into a detailed report that includes the location, type, and frequency of every detected off-target event. Our specialists then consult with you to interpret the data.
Applications
Therapeutic Glycoprotein Production
Ensuring the genetic stability of mammalian or yeast chassis used for manufacturing monoclonal antibodies or vaccines. Our service prevents off-target genome editing from disrupting the precise glycosylation patterns.
Industrial Biofuel Synthesis
Optimizing microbial cell factories for the high-yield production of bio-based chemicals. By eliminating off-target mutations, we ensure that metabolic flux is directed entirely toward the target product without diverting resources to unintended pathways.
Gut Microbiome Engineering
Developing safe and stable probiotic strains with enhanced functional properties. Off-target analysis ensures that engineered traits do not inadvertently introduce antibiotic resistance or metabolic toxicity within the human host environment.
Agricultural Biotechnology
Engineering plant-associated microbes to improve crop yields or nitrogen fixation. Our rigorous validation processes ensure that modified strains remain stable in complex environmental conditions.
Advantages
Exceptional Detection Sensitivity
Our NGS-based validation detects mutations at frequencies as low as 0.1%. This ensures that even the most elusive off-target events are identified before they impact your large-scale fermentation or production runs.
Broad Chassis Compatibility
We have extensive experience working with a wide range of hosts, from common laboratory strains to non-standard industrial microbes. Our protocols are adaptable to the specific genomic complexities of your organism.
Integrated Bioinformatics Expertise
Our dedicated computational team provides more than just raw data. We deliver actionable insights, including variant annotation and impact assessments on metabolic pathways.
End-to-End Solutions
From initial gRNA design to final strain certification, we offer a seamless one-stop service. This integrated approach reduces turnaround times and eliminates the communication gaps often found when using multiple service providers.
Frequently Asked Questions
Customer Review
"We were developing a Pichia strain for complex glycoprotein synthesis and were concerned about the stability of the glycosylation cluster we inserted. Their analysis identified a potential off-target gene in a regulatory region we hadn't considered."
– W.Q., Biopharmaceutical Development Firm
"Their expertise in both glycobiology and genome editing is a rare combination. The off-target validation gave us the confidence needed to move our probiotic engineering project into the pilot phase."
– A.R., Industrial Biotechnology Startup
"We used their off-targeted genome editing service to certify a new E. coli chassis for high-yield rare sugar production. The deep sequencing data were clean, and the bioinformatics interpretation was top-tier."
CD BioGlyco provides a sophisticated and comprehensive off-target genome editing service tailored for the rigorous demands of chassis development in synthetic glycobiology. By combining unbiased discovery, ultra-deep sequencing, and expert consultation, we ensure your engineered strains are optimized for safety, stability, and performance. Please feel free to contact us to help you achieve unprecedented precision in your next chassis engineering project.
For research use only. Not intended for any clinical use.
